Zalevsky Jonathan - Insider Non-Derivative Transactions at NEKTAR THERAPEUTICS (NKTR) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Aug 19, 2024, Zalevsky Jonathan's relationship to NEKTAR THERAPEUTICS (NKTR) is Officer (Chief R&D Officer), and currently has 250,804 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other NKTR insiders.
Data Source: SEC.
Zalevsky Jonathan - Insider Non-Derivative Transactions of NKTR Common Stock
Zalevsky Jonathan - Insider Non-Derivative Transactions at NKTR
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Aug 20, 2024 | Sell -- (Common Stock) | 6866 | 1.28 | 250804 |
| May 18, 2024 | Sell -- (Common Stock) | 7355 | 1.75 | 257670 |
| Feb 21, 2024 | Sell -- (Common Stock) | 9014 | 0.68 | 265025 |
| Nov 18, 2023 | Sell -- (Common Stock) | 9646 | 0.49 | 274039 |
| Aug 17, 2023 | Sell -- (Common Stock) | 9703 | 0.78 | 283685 |
| May 17, 2023 | Sell -- (Common Stock) | 9791 | 0.72 | 293388 |
| Feb 17, 2023 | Sell -- (Common Stock) | 10484 | 3 | 303179 |